ES525007A0 - Un procedimiento para producir derivados de tiazol - Google Patents

Un procedimiento para producir derivados de tiazol

Info

Publication number
ES525007A0
ES525007A0 ES525007A ES525007A ES525007A0 ES 525007 A0 ES525007 A0 ES 525007A0 ES 525007 A ES525007 A ES 525007A ES 525007 A ES525007 A ES 525007A ES 525007 A0 ES525007 A0 ES 525007A0
Authority
ES
Spain
Prior art keywords
procedure
producing
tiazole
derivatives
tiazole derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES525007A
Other languages
English (en)
Other versions
ES8502438A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis UK Holdings Ltd
Original Assignee
Hoechst UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst UK Ltd filed Critical Hoechst UK Ltd
Publication of ES525007A0 publication Critical patent/ES525007A0/es
Publication of ES8502438A1 publication Critical patent/ES8502438A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/30Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/86Oxygen and sulfur atoms, e.g. thiohydantoin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/96Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ES525007A 1982-08-20 1983-08-18 Un procedimiento para producir derivados de tiazol Expired ES8502438A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8224024 1982-08-20

Publications (2)

Publication Number Publication Date
ES525007A0 true ES525007A0 (es) 1985-01-01
ES8502438A1 ES8502438A1 (es) 1985-01-01

Family

ID=10532436

Family Applications (2)

Application Number Title Priority Date Filing Date
ES525007A Expired ES8502438A1 (es) 1982-08-20 1983-08-18 Un procedimiento para producir derivados de tiazol
ES527237A Expired ES8504790A1 (es) 1982-08-20 1983-11-14 Un procedimiento para producir derivados de tiazol

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES527237A Expired ES8504790A1 (es) 1982-08-20 1983-11-14 Un procedimiento para producir derivados de tiazol

Country Status (11)

Country Link
US (1) US4649145A (es)
EP (1) EP0102026A3 (es)
JP (1) JPS5953483A (es)
KR (1) KR840005723A (es)
AU (1) AU1816883A (es)
DK (1) DK382283A (es)
ES (2) ES8502438A1 (es)
GB (1) GB2125404B (es)
GR (1) GR79384B (es)
PT (1) PT77221B (es)
ZA (1) ZA836129B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4585781A (en) * 1982-12-31 1986-04-29 Glaxo Group Limited Heterocyclic derivatives
GB8311443D0 (en) * 1983-04-27 1983-06-02 Smith Kline French Lab Chemical compounds
JPH01156965A (ja) * 1987-09-29 1989-06-20 Taiho Yakuhin Kogyo Kk チオヒダントイン化合物
GB9611046D0 (en) * 1996-05-25 1996-07-31 Wivenhoe Techn Ltd Pharmacological compounds
WO2002053155A1 (en) * 2000-12-30 2002-07-11 Geron Corporation Telomerase inhibitor
FR2919608B1 (fr) * 2007-08-01 2012-10-05 Univ Rennes Derives d'imidazolones,procede de preparation et applications biologiques
KR101404185B1 (ko) * 2012-03-09 2014-06-11 연세대학교 산학협력단 Wnt/β-카테닌 신호전달계와 관련된 질병의 예방 및 치료용 약학 조성물
EP4196793A1 (en) 2020-08-11 2023-06-21 Université de Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1419994A (en) * 1973-05-03 1976-01-07 Smith Kline French Lab Heterocyclicalkylaminotheterocyclic compounds methods for their preparation and compositions comprising them
GB2001624B (en) * 1977-04-20 1982-03-03 Ici Ltd Guanidine derivatives processes for their manufacture and pharmaceutical compositions containing them
US4374836A (en) * 1978-10-16 1983-02-22 Imperial Chemical Industries Ltd. Antisecretory heterocyclic derivatives, process for their manufacture and pharmaceutical compositions containing them
DE3069889D1 (en) * 1979-01-18 1985-02-14 Ici Plc Guanidine derivatives, processes for their manufacture and pharmaceutical compositions containing them
IL61233A (en) * 1979-10-24 1984-08-31 Smith Kline French Lab Guanidino thiazolylalkylamino(alkylthioalkylamino)nitro pyrroles,process for their preparation and pharmaceutical compositions containing them
GR71929B (es) * 1979-11-13 1983-08-19 Ici Ltd

Also Published As

Publication number Publication date
AU1816883A (en) 1984-02-23
EP0102026A2 (en) 1984-03-07
PT77221B (en) 1986-03-18
KR840005723A (ko) 1984-11-16
GB2125404B (en) 1985-11-13
PT77221A (en) 1983-09-01
JPS5953483A (ja) 1984-03-28
US4649145A (en) 1987-03-10
ES527237A0 (es) 1985-04-16
ZA836129B (en) 1984-04-25
ES8504790A1 (es) 1985-04-16
GB8322359D0 (en) 1983-09-21
DK382283A (da) 1984-02-21
EP0102026A3 (en) 1984-05-16
GB2125404A (en) 1984-03-07
ES8502438A1 (es) 1985-01-01
GR79384B (es) 1984-10-22
DK382283D0 (da) 1983-08-19

Similar Documents

Publication Publication Date Title
AR227533A1 (es) Un procedimiento para producir derivados fenetilaminicos sufamoil sustituidos
ES538721A0 (es) Un procedimiento para preparar derivados de guanina
ES532537A0 (es) Un procedimiento para preparar un derivado de carbostirilo
ES530916A0 (es) Un procedimiento para preparar derivados de pirimidina
ES530024A0 (es) Un procedimiento para preparar derivados de pirazinona
ES537104A0 (es) Un procedimiento para preparar derivados de tiazina
ES536865A0 (es) Un procedimiento para producir un complejo de platino-diamino
ES528304A0 (es) Un procedimiento para preparar derivados de pirimidona
ES534297A0 (es) Un procedimiento para preparar derivados de cefem
ES536152A0 (es) Un procedimiento para producir l-arginina
ES523419A0 (es) Un metodo para preparar derivados de 4-hidroxi-2-quinolona
ES535568A0 (es) Un procedimiento para preparar derivados de piridazinona
ES530016A0 (es) Un metodo para preparar derivados de 3-metilflavona
ES526088A0 (es) Un procedimiento para preparar derivados de ciclobutano
ES536293A0 (es) Un procedimiento para producir derivados de acilindol
ES525007A0 (es) Un procedimiento para producir derivados de tiazol
ES535847A0 (es) Un procedimiento para producir un uroquinasa-zimogeno
ES534356A0 (es) Un metodo para preparar derivados de fenotiazina
ES532485A0 (es) Procedimiento para producir derivados de tiatriazina
ES526177A0 (es) Un procedimiento para preparar derivados de pirimidona
ES534701A0 (es) Un procedimiento para producir l-isoleucina
ES529478A0 (es) Un procedimiento para preparar derivados de mitomicina
ES530855A0 (es) Un procedimiento para preparar derivados de benzotiazina
ES527738A0 (es) Un procedimiento para preparar derivados de piridona
ES527789A0 (es) Un procedimiento para preparar derivados de cicloalquenilo